233 related articles for article (PubMed ID: 19824568)
21. Cardiovascular complications in end-stage renal disease and hemodialysis patients.
Kes P; Drusko D; Rupcić V
Acta Med Croatica; 1996; 50(4-5):199-208. PubMed ID: 9046118
[TBL] [Abstract][Full Text] [Related]
22. Systemic consequences of poor oral health in chronic kidney disease patients.
Akar H; Akar GC; Carrero JJ; Stenvinkel P; Lindholm B
Clin J Am Soc Nephrol; 2011 Jan; 6(1):218-26. PubMed ID: 21115624
[TBL] [Abstract][Full Text] [Related]
23. Dental management of people with renal disease and renal transplants.
Ferguson CA; Whyman RA
N Z Dent J; 1998 Sep; 94(417):125-30. PubMed ID: 9775650
[TBL] [Abstract][Full Text] [Related]
24. Inflammation, cardiovascular disease and destructive periodontal diseases. The evolving role of the dental profession.
Craig RG
N Y State Dent J; 2004; 70(5):22-6. PubMed ID: 15332563
[TBL] [Abstract][Full Text] [Related]
25. Quotidian hemodialysis and inflammation associated with chronic kidney disease.
Hamlett L; Haragsim L
Adv Chronic Kidney Dis; 2007 Jul; 14(3):e35-42. PubMed ID: 17603973
[TBL] [Abstract][Full Text] [Related]
26. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
27. Optimizing end-stage renal disease therapy for the patient with diabetes mellitus.
Friedlander MA; Hricik DE
Semin Nephrol; 1997 Jul; 17(4):331-45. PubMed ID: 9241718
[TBL] [Abstract][Full Text] [Related]
28. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular outcome in asymptomatic hemodialysis patients submitted to aggressive medical therapy: results of a four-year follow-up.
Summaria F; Manca Di Villahermosa S; Tedesco M; Lonzi M; Colarieti G; Chamoun MG; Taccone Gallucci M
Minerva Cardioangiol; 2011 Apr; 59(2):121-6. PubMed ID: 21242949
[TBL] [Abstract][Full Text] [Related]
30. End stage renal disease and its dental management.
Sharma DC; Pradeep AR
N Y State Dent J; 2007 Jan; 73(1):43-7. PubMed ID: 17378316
[TBL] [Abstract][Full Text] [Related]
31. [Cardioprotection: an essential component for predialysis chronic renal failure treatment].
Jungers P; Qualim Z; Nguyen-Khoa T; Massy Z; London G
Nephrologie; 2003; 24(2):79-88. PubMed ID: 12723513
[TBL] [Abstract][Full Text] [Related]
32. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
Heinz J; Kropf S; Luley C; Dierkes J
Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
[TBL] [Abstract][Full Text] [Related]
33. Dental diseases in a Jordanian population on renal dialysis.
Al-Wahadni A; Al-Omari MA
Quintessence Int; 2003 May; 34(5):343-7. PubMed ID: 12795352
[TBL] [Abstract][Full Text] [Related]
34. Periodontal diseases--a modifiable source of systemic inflammation for the end-stage renal disease patient on haemodialysis therapy?
Craig RG; Kotanko P; Kamer AR; Levin NW
Nephrol Dial Transplant; 2007 Feb; 22(2):312-5. PubMed ID: 17071738
[No Abstract] [Full Text] [Related]
35. C-reactive protein and end-stage renal disease.
Lacson E; Levin NW
Semin Dial; 2004; 17(6):438-48. PubMed ID: 15660574
[TBL] [Abstract][Full Text] [Related]
36. [Oral cavity pathology by renal failure].
Maĭborodin IV; Minikeev IM; Kim SA; Ragimova TM
Stomatologiia (Mosk); 2014; 93(1):72-9. PubMed ID: 24719973
[TBL] [Abstract][Full Text] [Related]
37. Special characteristics of atherosclerosis in chronic renal failure.
Amann K; Tyralla K; Gross ML; Eifert T; Adamczak M; Ritz E
Clin Nephrol; 2003 Jul; 60 Suppl 1():S13-21. PubMed ID: 12940530
[TBL] [Abstract][Full Text] [Related]
38. Incidence of atherosclerotic cardiovascular disease among HIV patients receiving dialysis.
Oberai PC; Dalal D; Zhang L; Wang C; Eustace J; Parekh RS
Am J Kidney Dis; 2006 May; 47(5):848-55. PubMed ID: 16632024
[TBL] [Abstract][Full Text] [Related]
39. Interactions between inflammation, oxidative stress, and endothelial dysfunction in end-stage renal disease.
Stenvinkel P
J Ren Nutr; 2003 Apr; 13(2):144-8. PubMed ID: 12671839
[TBL] [Abstract][Full Text] [Related]
40. [Malnutrition -- inflammation -- atherosclerosis (MIA syndrome) in patients with renal failure].
Pawlaczyk K; Oko A; Lindholm B; Czekalski S
Pol Merkur Lekarski; 2003 Oct; 15(88):334-41; discussion 341-3. PubMed ID: 14974361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
